Vaxxinity Investor Relations Material
Latest events
Q4 2023
27 Mar, 2024
Corporate Presentation
12 Mar, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Vaxxinity Inc
Access all reports
Vaxxinity Inc. is a biotechnology company focused on developing immunotherapies for chronic diseases and infectious conditions. The company specializes in vaccine-based treatments designed to harness the immune system for conditions such as neurodegenerative disorders, cardiovascular diseases, and viral infections. The company is headquartered in Dallas, Texas, and its shares are listed on the NASDAQ.
Latest articles
)
Novo Nordisk: Tipping the Scale of Innovation
Taking a look at the company behind Ozempic and Wegovy and diving into their history, business, and the challenges it now faces
8 Aug 2025
)
Global Doughmination: Breaking Down Domino's Pizza
Inside the rise of Domino's Pizza: how franchising, delivery control, and supply chain mastery built one of the world's most efficient food empires.
18 Jul 2025
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
Ticker symbol
VAXX
Country
🇺🇸 United States